Antifungal prophylaxis with voriconazole in allogeneic hematopoietic stem cell transplantation recipients

被引：0
|
作者：
Magalhaes-Silverman, M [1 ]
Carter, T [1 ]
Hohl, R [1 ]
Shamsuddin, H [1 ]
Gingrich, R [1 ]
机构：
[1] Univ Iowa, Iowa City, IA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.262
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
262
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [41] Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipients
    Allinson, Katherine
    Kolve, Hedwig
    Gumbinger, Hans G.
    Vormoor, H. Josef
    Ehlert, Karoline
    Groll, Andreas H.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 734 - 742
  • [42] Oral voriconazole for prophylaxis of fungal infections during allogeneic hematopoietic stem cell transplantation in patients at risk.
    Schleuning, M
    Judith, D
    Thoedtmann, R
    Baurmann, H
    Schwerdtfeger, R
    BLOOD, 2003, 102 (11) : 442B - 442B
  • [43] Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation
    Martin, T.
    Sharma, M.
    Damon, L.
    Kaplan, L.
    Guglielmo, B. J.
    Working, M.
    O'Malley, R.
    Hwang, J.
    Linker, C.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (01) : 45 - 50
  • [44] Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
    N S Hamza
    M A Ghannoum
    H M Lazarus
    Bone Marrow Transplantation, 2004, 34 : 377 - 389
  • [45] Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
    Hamza, NS
    Ghannoum, MA
    Lazarus, HM
    BONE MARROW TRANSPLANTATION, 2004, 34 (05) : 377 - 389
  • [46] Meropenem as antibacterial prophylaxis for allogeneic stem cell transplantation recipients
    Muina, B. S.
    Castilla-Llorente, C.
    Heras, I.
    Gallego, R.
    Nieto, J.
    de Arriba, F.
    Osma, M.
    Vicente, V.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S233 - S234
  • [47] Variable magnitude of drug interaction between oral voriconazole and cyclosporine A in recipients of allogeneic hematopoietic stem cell transplantation
    Kikuchi, Taku
    Mori, Takehiko
    Yamane, Akiko
    Kato, Jun
    Kohashi, Sumiko
    Okamoto, Shinichiro
    CLINICAL TRANSPLANTATION, 2012, 26 (05) : E544 - E548
  • [48] Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
    Ye, Peipei
    Pei, Renzhi
    Hu, Youqian
    Chen, Dong
    Li, Shuangyue
    Cao, Junjie
    Li, Fenglin
    Wu, Mengjie
    Fang, Ying
    Lu, Ying
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [49] Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis
    Pavie, J
    Lacroix, C
    Hermoso, DG
    Robin, M
    Ferry, C
    Bergeron, A
    Feuilhade, M
    Dromer, F
    Gluckman, E
    Molina, JM
    Ribaud, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (09) : 4902 - 4904
  • [50] Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study
    Peipei Ye
    Renzhi Pei
    Youqian Hu
    Dong Chen
    Shuangyue Li
    Junjie Cao
    Fenglin Li
    Mengjie Wu
    Ying Fang
    Ying Lu
    BMC Infectious Diseases, 22
12345